BMJ 2007;335:929-932 (3 November), doi:10.1136/bmj.39346.696620.AE
Clinical Review
Management of sepsis
Iain Mackenzie, consultant in intensive care medicine and anaesthesia1,
Andrew Lever, professor of infectious diseases and honorary consultant physician2
1 John Farman Intensive Care Unit, Box 17, Addenbrooke's Hospital, Cambridge CB2 2QQ,
2 Department of Medicine, University of Cambridge, Cambridge
Correspondence to: I Mackenzie iain@number2.demon.co.uk
| The first 150 words of the full text of this article appear below. |
This is the second of two reviews—the first discussed the definition, epidemiology, and diagnosis of sepsis, whereas this one focuses on management and outcome. Management of sepsis can conveniently be divided into general supportive measures and specific treatment.
Summary points
- A favourable outcome depends on early, aggressive, treatment
- Antimicrobial treatment must take into account both patient susceptibilities and local resistance patterns; advice from infectious disease or microbiology colleagues is often helpful
- Volume resuscitation and cardiovascular support should be titrated to simple clinical end points
- Subtle signs of organ hypoperfusion should be sought in physically robust patients
- The role of activated protein C and low dose steroids remains to be clarified
| |
What are the general supportive measures?
Circulatory compromise arises from the combination of vasodilatation, capillary leak, and reduced myocardial contractility, and needs early correction. Whether crystalloids or colloids are better for volume resuscitation remains unresolved. Few people now use human albumin after a controversial meta-analysis concluded that albumin . . . [Full text of this article]
Box 1 Clinical and functional end points for titration of fluid resuscitation
Box 2 Resuscitation end points in the study by Rivers and colleagues6
What specific treatments are available?
AntimicrobialsCorticosteroidsImmunoglobulins and statinsHMGB-1Multiple system organ failure and outcome
Box 3 Common sequence of organ failurePrimary involvementSecondary involvementTertiary involvementConclusion
Sources and selection criteriaTips for non-specialistsAdditional educational resourcesInformation resources for patients

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Relevant Articles
-
Surviving sepsis campaign's recommendations
- Lindsay E M Reid
BMJ 2007 335: 1007.
[Extract]
[Full Text]
[PDF]
-
Going to extremes
- Tony Delamothe
BMJ 2007 335: 0.
[Extract]
[Full Text]
-
Sepsis: definition, epidemiology, and diagnosis
- Andrew Lever and Iain Mackenzie
BMJ 2007 335: 879-883.
[Extract]
[Full Text]
[PDF]
-
Human albumin administration in critically ill patients: systematic review of randomised controlled trials Why albumin may not work
- Cochrane Injuries Group Albumin Reviewers and Cochrane Injuries Group Albumin Reviewers
BMJ 1998 317: 235-240.
[Abstract]
[Full Text]
[PDF]
This article has been cited by other articles:
-
Reid, L. E M
(2007). Surviving sepsis campaign's recommendations. BMJ
335: 1007-1007
[Full text]
Rapid Responses:
Read all Rapid Responses
- Diagnosis and management of sepsis - at the bedside
- Lindsay EM Reid
bmj.com, 8 Nov 2007
[Full text]
- Our experience in the management of sepsis
- Belkys Rodriguez Llerena, et al.
bmj.com, 11 Nov 2007
[Full text]
- Don’t overlook supportive therapy for sepsis
- Akashdeep Singh, et al.
bmj.com, 13 Nov 2007
[Full text]
- Human recombinant activated protein C for severe sepsis
- Georgia Salanti, et al.
bmj.com, 16 Nov 2007
[Full text]
- Steroids in sepsis
- Iain D Drummond
bmj.com, 19 Nov 2007
[Full text]
- Predicted, Ideal or Actual Body Weight ?
- M Samer Abdalla
bmj.com, 3 Dec 2007
[Full text]
- Re: Predicted, Ideal or Actual Body Weight ?
- Iain M Mackenzie, et al.
bmj.com, 3 Dec 2007
[Full text]